Scholarlink

<p>Condensation of 2,3-diaminopyridine with 2,4-dihyrodybenzaldehyde yielded a 4,4’-[(1E,1 ~ E)-(pyridine-2,3-diyl)bis(azanylylidene)]bis(methanylylidene)bis(benzene-1,3-diol) monobasic tridentate Schiff base ligand (HL) with an ONN donor sequence. Elemental analyses, conductivity tests, magnetic susceptibility data, FT-IR, UV–vis spectra, x-ray diffraction, and mass spectrum data of the ligand and its complexes were used for the characterization of the structures. Computational HF/3-21G calculations were performed to optimize their geometrical structures and assess their HOMO–LUMO energy gaps. The low molar conductance of the complexes indicates that they are not electrolytic. From the spectrophotometric and gravimetric analyses, the complexes <b>(2–4)</b> are in the ratio of 1:2, while complexes <b>(1</b> &amp; <b>5)</b> (1:1) metal to ligand. 2,3-Diaminopyridine, 2,4-dihydroxybenzaldehyde, ligand (HL) and its complexes were screened for antibacterial and antifungal activities against some bacterial (<i>Enterococcus faecalis</i>, <i>Salmonella typhi</i>, and <i>Staphylococcus epidermidis</i>) and fungal isolates (<i>Aspergillus flavus</i>, <i>Alternaria solani</i>, and <i>Candida albicans</i>). The result reveals that 2,4-dihyrodybenzaldehyde has the strongest antibacterial activity among the other compounds followed by Mn(II) complex. The antimicrobial activity increases by increasing the compound concentration. To assess the inhibitory impact of ligand and its complexes on binding sites of <i>B. cereus</i> (PDB ID: 1FEZ), <i>S. epidermidis</i> (PDB ID: 3KP7), <i>E. faecalis</i> (PDB ID: 5V5U) and <i>S. typhi</i> (PDB ID: 5V2W) proteins, molecular modeling has been implemented offer a fresh concept for medication design. Molecular docking studies confirmed strong binding interactions between the metal complexes and bacterial proteins, validating their biological potential. These findings demonstrate the promising antimicrobial properties of Schiff base metal complexes, making them potential candidates for pharmaceutical and medicinal applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Synthesis, characterization, biological evaluation and molecular docking of a Schiff base ligand and its metal complexes

  • 期刊论文

  • 发表日期：

    2025年5月14日

查看全文
  • Elsayed M. AbouElleef,
  • Rania A. Saad,
  • M. A. Diab,
  • M. M. El-Zahed,
  • A. Z. El-Sonbati,
  • Sh. M. Morgan

摘要

Condensation of 2,3-diaminopyridine with 2,4-dihyrodybenzaldehyde yielded a 4,4’-[(1E,1 ~ E)-(pyridine-2,3-diyl)bis(azanylylidene)]bis(methanylylidene)bis(benzene-1,3-diol) monobasic tridentate Schiff base ligand (HL) with an ONN donor sequence. Elemental analyses, conductivity tests, magnetic susceptibility data, FT-IR, UV–vis spectra, x-ray diffraction, and mass spectrum data of the ligand and its complexes were used for the characterization of the structures. Computational HF/3-21G calculations were performed to optimize their geometrical structures and assess their HOMO–LUMO energy gaps. The low molar conductance of the complexes indicates that they are not electrolytic. From the spectrophotometric and gravimetric analyses, the complexes (2–4) are in the ratio of 1:2, while complexes (1 & 5) (1:1) metal to ligand. 2,3-Diaminopyridine, 2,4-dihydroxybenzaldehyde, ligand (HL) and its complexes were screened for antibacterial and antifungal activities against some bacterial (Enterococcus faecalis, Salmonella typhi, and Staphylococcus epidermidis) and fungal isolates (Aspergillus flavus, Alternaria solani, and Candida albicans). The result reveals that 2,4-dihyrodybenzaldehyde has the strongest antibacterial activity among the other compounds followed by Mn(II) complex. The antimicrobial activity increases by increasing the compound concentration. To assess the inhibitory impact of ligand and its complexes on binding sites of B. cereus (PDB ID: 1FEZ), S. epidermidis (PDB ID: 3KP7), E. faecalis (PDB ID: 5V5U) and S. typhi (PDB ID: 5V2W) proteins, molecular modeling has been implemented offer a fresh concept for medication design. Molecular docking studies confirmed strong binding interactions between the metal complexes and bacterial proteins, validating their biological potential. These findings demonstrate the promising antimicrobial properties of Schiff base metal complexes, making them potential candidates for pharmaceutical and medicinal applications.